GlassScriptPhysician profile
Melvin Munoz-Guzman
NPI 1144490061
$2,942.61
in general payments reported to CMS, 2019-2025
20 companies · $532 in 2025
The $532 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $692 · 2020: $140 · 2021: $533 · 2022: $241 · 2023: $356 · 2024: $449 · 2025: $532.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,338.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,337.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $535.99 | 2023-2025 | Miebo, Xiidra, Infuse |
| Abbvie INC. | $292.95 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $276.16 | 2019-2023 | |
| Kala Pharmaceuticals, INC. | $265.68 | 2021 | |
| Shire North American Group INC | $257.32 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $240.42 | 2019-2021 | |
| Alcon Vision LLC | $199.25 | 2022-2025 | Eysuvis, Tryptyr, Rocklatan |
| Oyster Point Pharma, INC. | $186.66 | 2023-2025 | Tyrvaya, Ryzumvi |
| Allergan, INC. | $162.88 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $130.07 | 2019-2025 | |
| Tarsus Pharmaceuticals, INC. | $111.42 | 2024-2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $56.29 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $45.80 | 2021-2025 | Eylea Hd |
| Eyepoint US, INC. | $40.91 | 2020-2021 | |
| Alimera Sciences, INC. | $34.58 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis, INC | $26.97 | 2021 | |
| Spark Therapeutics, INC. | $24.04 | 2022 | |
| Rayner Intraocular Lenses Limited | $23.30 | 2023 | Rayone Spheric, Omidria, Rayone Aspheric |
| Omeros Corporation | $16.70 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $15.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melvin Munoz-Guzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.